探讨腹股沟疝伴恶性肿瘤患者在恶性肿瘤稳定期行腹股沟疝修补术的可行性。

选取58家医院2017年1月1日至12月31日收治的10 964例腹股沟疝住院患者，根据腹股沟疝是否伴有恶性肿瘤以及手术方式分为腹股沟疝伴恶性肿瘤行腹腔镜疝修补术（恶性肿瘤＋腔镜组）、腹股沟疝伴恶性肿瘤行开放式疝修补术（恶性肿瘤＋开放组）、腹股沟疝不伴恶性肿瘤行腹腔镜疝修补术（非恶性肿瘤＋腔镜组）、腹股沟疝不伴恶性肿瘤行开放式疝修补术（非恶性肿瘤＋开放组），比较各项围手术期指标。

恶性肿瘤＋腔镜组手术时间、术中出血量、围手术期不良事件（出血、血清肿、静脉血栓栓塞症）发生率分别为（71.05±33.64）min、（7.82±5.46）ml、3.62%、3.62%、0，与非恶性肿瘤＋腔镜组（77.04±35.68）min、（8.06±7.36）ml、2.67%、2.37%、0.25%相比较，差异无统计学意义（P>0.05）；恶性肿瘤＋开放组手术时间、术中出血量、围手术期不良事件（出血、血清肿、静脉血栓栓塞症）发生率分别为（76.00±34.69）min、（7.56±6.41）ml、0.70%、2.44%、0，与非恶性肿瘤＋开放组（79.65±42.07）min、（8.33±7.96）ml、2.19%、2.19%、0.02%相比较，差异无统计学意义（P>0.05）。

从围手术期表现来看，腹股沟疝伴恶性肿瘤患者在恶性肿瘤稳定期行腹股沟疝修补术是安全可行的，本研究可为今后我们在临床上处理此类患者提供科学依据和理论指导。

To investigate the feasibility of inguinal hernia repair in patients at stable stage of malignant tumors.

A total of 10 964 hospitalized patients with inguinal hernia from 58 hospitals during January 1st, 2017 to December 31st, 2017 were included and divided into 4 groups according to surgical technique and whether the patient had a history of malignant tumor: (1) LM⁺, laparoscopic hernia repair on patients with malignant tumor; (2) OM⁺, open hernia repair on patients with malignant tumor; (3) LM^-, laparoscopic hernia repair on patients without malignant tumor; (4) OM^-, open hernia repair on patients without malignant tumor. The perioperative parameters were retrospectively compared.

The time of operation, the volume of intraoperative bleeding and the incidence of perioperative adverse events (hemorrhage, seroma and VTE) in LM⁺ group were (71.05±33.64) minutes vs (77.04±35.68) minutes, (7.82±5.46) ml vs (8.06±7.36) ml, (3.62% vs 2.67%), (3.62% vs 2.37%), (0 vs 0.25%), respectively, compared with LM^-, there were not statistically different (P>0.05); the time of operation, the volume of intraoperative bleeding and the incidence of perioperative adverse events (hemorrhage, seroma and VTE) in OM⁺ group were (76.00±34.69) minutes vs (79.65±42.07) minutes, (7.56±6.41) ml vs (8.33±7.96) ml, (0.70% vs 2.19%), (2.44% vs 2.19%), (0 vs 0.02%), respectively, compared with OM^-, there were not statistically different (P>0.05).

Judging from the perioperative parameters, inguinal hernia repair is safe and feasible to be performed on patients with malignant tumor, and this study can provide some evidences and guidance for clinical management.